Setting a TRAP for pandemic-causing viruses
Gilead 2020: HIV … and COVID?
Amgen 2020: 40-Year-Old Pioneer
AstraZeneca 2020: Driven by Covid-19
Sanofi 2020: New challenges
FDA gives COVID-19 vaccine ‘advice’ after White House blocks guidance
Every COVID-19 case seems different; these scientists want to know why
New research supports sofosbuvir in combination with other antivirals for COVID-19
How the leading coronavirus vaccines work
UQ tech could offer ‘faster, cheaper and mobile’ COVID-19 diagnosis
Race for COVID-19 vaccine hots up as EMA begins review of BioNTech/Pfizer jab
“One-Pot,” Fluorescence-Based COVID-19 Test is Quick and Easy
Sigh, yes, the ‘COVID virus’ is real
Harvard Wyss Institute’s nasal swab and toehold switch technologies licensed to Agile Biodetection
Diagnosing COVID-19 in just 30 minutes
Trump’s Treatments: Regeneron’s Antibodies and Gilead’s Remdesivir Explained
New COVID test doesn’t use scarce reagents, catches all but the least infectious
Spatial: The Next Omics Frontier
The Empire Of Uncertainty
Promising COVID-19 rapid test technology enters phase 1 of NIH challenge
Breaking COVID-19’s ‘clutch’ to stop its spread
App analyzes coronavirus genome on a smartphone
One COVID-19 Shot, Two Approaches
Research on emerging COVID-19 (target, mechanism, and therapeutics)
RNA for Medical Analysis
Kits and reagents and viruses
Ultrapotent antibody mix blocks COVID-19 virus attachment
Color-coded biosensor illuminates in real time how viruses attack hosts
BIOCAD will produce the COVID-19 vaccine developed by Gamalei Institute
Norwegian university supplying COVID-19 test kits to India, Denmark